Serious adverse events following immunization after ChAdOx1 nCov-19 vaccination in India: a single center experience

Table 1 laboratory investigations: day 2, 4, 5, 6, 7 post ChAdOx1 nCov-19 vaccination Days post vaccination Day 2 Day 4 Day 5 Day 6 Day 7 Haemoglobin (g/dl) 12.5 9.7 10.6 10.8 11.0 White Blood Cell count (cells/mm3) 3300 2800 3200 4200 4700 Platelet (lacs/mm3) 1.8 1.2 1.0 1.4 1.8 A 50-year-old elder...

Full description

Saved in:
Bibliographic Details
Published in:The Pan African medical journal 2021-09, Vol.40
Main Authors: Rajaram, Maurya Miteshkumar, Renju, Ravi, Pushparajan Libby
Format: Article
Language:English
Subjects:
Analgesics
Blood
Chicken pox
Coronaviruses
COVID-19 vaccines
Fever
Laboratories
Letter to the Editors
Skin
Surveillance
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Table 1 laboratory investigations: day 2, 4, 5, 6, 7 post ChAdOx1 nCov-19 vaccination Days post vaccination Day 2 Day 4 Day 5 Day 6 Day 7 Haemoglobin (g/dl) 12.5 9.7 10.6 10.8 11.0 White Blood Cell count (cells/mm3) 3300 2800 3200 4200 4700 Platelet (lacs/mm3) 1.8 1.2 1.0 1.4 1.8 A 50-year-old elderly female, known hypothyroid for 15 years on tablet, levothyroxine 75 mcg daily, developed weakness all over the body with numbness over the whole left lower limb on the second day following vaccination. [...]a 30-year-old female with intradermal peeling blisters on her right hand (Figure 3, Figure 4) almost 18 hours after receiving the second dose of ChAdOx1 nCov-19 vaccine. [...]it becomes important to establish a robust vaccine surveillance system to track any adverse events following mass immunization against COVID-19. 1 Department of Clinical Pharmacology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India, 2 K Velayudhan Memorial Hospital, Alappuzha, Kerala, India
ISSN:1937-8688
DOI:10.11604/pamj.2021.40.66.29549